Long‐term outcomes in chronic hypersensitivity pneumonitis
Allergy2018Vol. 74(5), pp. 944–952
Citations Over TimeTop 10% of 2018 papers
Íñigo Ojanguren, Ferrán Morell, María Antonia Ramón, Ana Villar, Christian Romero, María Jesús Cruz, Xavier Muñoz
Abstract
CHP is a severe disease with a bad mid-term prognosis. Lymphocyte values in BAL and DLCO values at baseline, presence of honeycomb in HRCT, and UIP histologic pattern were found to be predictors of survival. Early accurate diagnosis of the disease is fundamental for prompt initiation of antigen avoidance.
Related Papers
- → New trajectories in the treatment of interstitial lung disease(2019)21 cited
- → Sequential Evaluation of Clinical and Immunological Findings in Hypersensitivity Pneumonitis: Serial Subclass Distribution of Antibodies(1994)13 cited
- → Rheumatoid arthritis-associated interstitial lung disease(2015)4 cited
- → Hypersensitivity Pneumonitis Versus Usual Interstitial Pneumonia(2022)
- → Impact of antigen identification on transplant free survival in interstitial lung disease(2023)